These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25791093)

  • 1. Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Watts GF; Shaw JE; Pang J; Magliano DJ; Jennings GL; Carrington MJ
    Int J Cardiol; 2015 Apr; 185():69-71. PubMed ID: 25791093
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M; Watts GF; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3956-64. PubMed ID: 22893714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.
    Wald DS; Bangash FA; Bestwick JP
    Eur J Intern Med; 2015 Mar; 26(2):127-30. PubMed ID: 25682442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
    Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
    Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolaemia in Australia: new insights and developments.
    Hamilton-Craig IR; Watts GF
    Med J Aust; 2013 Feb; 198(2):72-3. PubMed ID: 23373481
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial hypercholesterolaemia: new treatment options.
    Ezzahti M; Sijbrands EJ; Mulder MT; Roeters van Lennep JE
    Neth J Med; 2013 Jun; 71(5):227-33. PubMed ID: 23799308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anacetrapib in familial hypercholesterolaemia: pros and cons.
    Raal FJ; Blom DJ
    Lancet; 2015 May; 385(9983):2124-6. PubMed ID: 25743172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polyphepan (lignin) as an hypocholesteremic agent].
    Frolkis AV; Abramzon MA; Kislova GD; Levanova VP
    Klin Med (Mosk); 1987 Jul; 65(7):48-52. PubMed ID: 3312799
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary artery bypass grafting in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Takemura H; Matsumoto Y; Mabuchi H; Watanabe Y
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):364-9. PubMed ID: 7853888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of risk factors for coronary artery disease in the community in eastern Nepal--a pilot study.
    Kalra S; Narain S; Karki P; Ansari JA; Ranabhat K; Basnet N
    J Assoc Physicians India; 2011 May; 59():300-1. PubMed ID: 21751607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
    Kastelein JJ; Besseling J; Shah S; Bergeron J; Langslet G; Hovingh GK; Al-Saady N; Koeijvoets M; Hunter J; Johnson-Levonas AO; Fable J; Sapre A; Mitchel Y
    Lancet; 2015 May; 385(9983):2153-61. PubMed ID: 25743173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of simvastatin therapy in treatment of hypercholesterolaemia in a hospital lipid clinic.
    Lepre F; Lee E
    Med J Aust; 1992 Apr; 156(7):510. PubMed ID: 1556987
    [No Abstract]   [Full Text] [Related]  

  • 14. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

  • 15. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum].
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak KJ; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Kubalska J; Bautembach-Minkowska J; Limon J; Zdrojewski T; Limon J; Banach M;
    Kardiol Pol; 2013; 71(10):1099-105. PubMed ID: 24197602
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems of long-term treatment in children with familial hypercholesterolaemia.
    West RJ
    Prog Clin Biol Res; 1985; 188():209-11. PubMed ID: 4059258
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
    Elis A; Zhou R; Stein EA
    Cardiol Young; 2014 Jun; 24(3):437-41. PubMed ID: 23659280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort.
    Glantz H; Thunström E; Herlitz J; Cederin B; Nasic S; Ejdebäck J; Peker Y
    Ann Am Thorac Soc; 2013 Aug; 10(4):350-6. PubMed ID: 23952854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolaemia.
    Nair DR; Sharifi M; Al-Rasadi K
    Curr Opin Cardiol; 2014 Jul; 29(4):381-8. PubMed ID: 24870549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.